Meeting Wed, 07/20/2022 - 12:00 Drug Utilization Review Board Meeting Information

Date
Media
Edit Implementation Schedule July 2022
PDL Announcement July 2022
New Drugs and Edits with no annual changes July 2022
Conduent Reports June 2022
Agenda
DUR Agenda July 2022
Minutes
DUR Minutes July 2022
Criteria
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
Ampyra June 2022
ATTR June 2022
Botulinum Toxin June 2022
DMD June 2022
Emsam June 2022
Gamifant June 2022
Immunoglobulin June 2022
Koselugo June 2022
Luxturna June 2022
Luxturna June 2022
Narcolepsy Inhibitors June 2022
NMOSD June 2022
Nuedexta June 2022
Oxandrin June 2022
Palforzia June 2022
Palynziq June 2022
Ranexa June 2022
Reblozyl June 2022
SSRI June 2022
Synagis June 2022
Tepezza June 2022
Tolvaptan June 2022
Xcopri June 2022
Zometa June 2022
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
Besremi June 2022
CAR T Cell June 2022
Crysvita June 2022
Enjaymo June 2022
Enzyme Deficiency Select Agents June 2022
Iron Injectable June 2022
LEMS June 2022
Manufacturers Requiring PA June 2022
PolyPharm June 2022
PTH and Other Agents June 2022
SNRI June 2022
TIMS Small Molecule JAK Inhibitor June 2022
Vyvgart June 2022
Page
Drug Utilization Review Board Meeting Information